KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Assets (2016 - 2025)

Historic Return on Assets for Eli Lilly (LLY) over the last 16 years, with Q4 2025 value amounting to 0.18%.

  • Eli Lilly's Return on Assets rose 400.0% to 0.18% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.18%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.22% for FY2025, which is 700.0% up from last year.
  • Eli Lilly's Return on Assets amounted to 0.18% in Q4 2025, which was up 400.0% from 0.17% recorded in Q3 2025.
  • Eli Lilly's Return on Assets' 5-year high stood at 0.18% during Q4 2025, with a 5-year trough of 0.03% in Q1 2021.
  • Over the past 5 years, Eli Lilly's median Return on Assets value was 0.12% (recorded in 2023), while the average stood at 0.11%.
  • As far as peak fluctuations go, Eli Lilly's Return on Assets skyrocketed by 1000bps in 2022, and later plummeted by -400bps in 2023.
  • Eli Lilly's Return on Assets (Quarter) stood at 0.12% in 2021, then grew by 12bps to 0.13% in 2022, then tumbled by -33bps to 0.09% in 2023, then soared by 60bps to 0.14% in 2024, then soared by 32bps to 0.18% in 2025.
  • Its last three reported values are 0.18% in Q4 2025, 0.17% for Q3 2025, and 0.15% during Q2 2025.